Home Specialties Pulmonology Severe Asthma Management
Pulmonology

Severe Asthma Management

Severe asthma is a form of asthma that stays uncontrolled despite high-dose inhalers and good technique. Management is specialist-led and may include phenotype testing, biologic therapy, careful monitoring, and a written action plan. The right combination depends on your inflammation type and overall health.

Read Full Article ↓
Severe Asthma Management

Introduction

If you are reading this, you most likely already know that your asthma is not behaving like other people’s asthma. You may have been told you have “severe asthma,” “difficult-to-treat asthma,” or “uncontrolled asthma.” You may still be having frequent attacks, waking at night breathless, needing repeated courses of oral steroids, or visiting the emergency department more often than feels normal — despite using your inhalers correctly.

Severe asthma is exhausting. It affects sleep, work, exercise, and emotional well-being. The fear of the next attack can be as draining as the attacks themselves. But severe asthma care has changed significantly over the past decade. With careful phenotyping (working out what type of inflammation is driving your asthma), targeted biologic medicines, and a structured action plan, many people who were previously stuck on oral steroids are now able to come off them and live with far fewer flare-ups.

This guide explains what severe asthma is, how it is evaluated, what the current treatment options look like, and what to expect as you move into specialist-led care. It is written for adults and parents of children who already have an asthma diagnosis and are now planning the next phase of management.

What Is Severe Asthma?

Asthma is a long-term condition in which the airways become inflamed, narrowed, and overly sensitive to triggers. Most people with asthma respond well to standard inhalers. “Severe asthma” is a specific medical category for the smaller group whose asthma does not come under control with these treatments.

The Global Initiative for Asthma (GINA) and the joint European Respiratory Society and American Thoracic Society (ERS/ATS) guidelines describe severe asthma as asthma that remains uncontrolled despite:

  • High-dose inhaled corticosteroids (ICS) combined with a long-acting bronchodilator
  • Good inhaler technique
  • Good adherence (you are actually taking the medicine as prescribed)
  • Treatment of other contributing conditions such as allergies, reflux, or sinus disease

This definition matters because before a diagnosis of severe asthma is made, doctors first try to rule out “difficult-to-treat asthma,” where the problem is not the disease itself but something that can be fixed — such as inhaler technique, an unidentified trigger, or another health issue.

Severe asthma is not just “bad asthma”

Severe asthma is a biologically distinct condition. The airways often show specific types of inflammation that can be measured and targeted. This is the basis for modern phenotype-driven treatment, where the medicine is matched to the type of inflammation rather than chosen by trial and error.

Types of severe asthma (phenotypes)

Specialists usually group severe asthma into broad phenotypes based on the underlying inflammation:

  • Type 2 (T2) high asthma: Driven by a particular pathway of immune inflammation. This includes severe allergic asthma and severe eosinophilic asthma (where a type of white blood cell called the eosinophil is raised). Most current biologic medicines target this pathway.
  • Non-T2 (T2 low) asthma: Less well understood and more common in people with later-onset asthma, obesity, or smoking history. Fewer targeted therapies are available, and treatment focuses on optimising inhalers, addressing contributing conditions, and using newer options where appropriate.
Cross-section diagram of asthmatic airway showing T2-high eosinophilic and non-T2 neutrophilic inflammation patterns with narrowed lumen.
Severe asthma airway inflammation types: ① T2-high eosinophilic inflammation with eosinophil cells, ② raised IgE antibodies in allergic T2 asthma, ③ thickened, narrowed airway wall, ④ non-T2 neutrophilic inflammation pattern.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Causes and Risk Factors

Severe asthma does not have a single cause. It usually develops from a combination of genetic susceptibility and environmental exposures over time. Factors associated with more severe disease include:

  • A family history of asthma or allergic disease
  • Strong allergic sensitisation (to dust mites, mould, pets, pollen, cockroach)
  • Early-life or current exposure to tobacco smoke
  • Air pollution, including indoor cooking smoke and outdoor particulate matter
  • Occupational exposures (flour, chemicals, isocyanates, animal proteins)
  • Obesity, which can both worsen asthma symptoms and reduce treatment response
  • Chronic rhinosinusitis with or without nasal polyps
  • Gastro-oesophageal reflux disease (GORD)
  • Obstructive sleep apnoea
  • Hormonal influences, particularly in women, where asthma can worsen around menstruation, pregnancy, or menopause

Some people develop severe asthma in childhood and carry it into adulthood. Others develop severe asthma for the first time as adults — sometimes after a viral chest infection — and this adult-onset form can be particularly aggressive.

How Severe Asthma Differs From Difficult-to-Treat Asthma

Before specialists confirm a diagnosis of severe asthma, they usually go through a careful checking process. This is because many people whose asthma seems uncontrolled actually have one or more reversible problems.

Common reasons asthma stays uncontrolled that are not true severe asthma include:

  • Incorrect inhaler technique (very common)
  • Missed doses or stopping the preventer inhaler when feeling well
  • Continued exposure to a trigger (a pet, mould in the home, an occupational allergen)
  • Untreated nasal disease, reflux, or sleep apnoea
  • Smoking or vaping
  • Other conditions that mimic asthma, such as vocal cord dysfunction, COPD, or chronic cough from another cause
Illustrated flowchart of severe asthma specialist diagnostic evaluation showing spirometry, FeNO test, blood tests, allergy testing, and chest imaging steps.
Severe asthma specialist evaluation pathway: ① spirometry / lung function, ② FeNO breath test, ③ blood eosinophil and IgE panel, ④ allergy skin-prick testing, ⑤ chest imaging.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

If your asthma remains uncontrolled despite standard treatment, you will usually be referred to a pulmonologist or a specialist severe asthma service. The aim of this evaluation is to confirm the diagnosis, identify your phenotype, and look for treatable contributing conditions.

Detailed history and symptom review

The specialist will go through your symptom pattern, attack frequency, oral steroid use, hospital visits, triggers, occupation, home environment, and family history. They will also review every inhaler you have used and ask you to demonstrate your technique.

Spirometry and pulmonary function tests

Spirometry measures how much air you can breathe out and how fast. The key number, FEV1 (forced expiratory volume in one second), helps quantify airflow obstruction. Reversibility testing — repeating spirometry after a bronchodilator — helps confirm asthma. More detailed pulmonary function tests can assess lung volumes and how well gases move across the lung.

FeNO (fractional exhaled nitric oxide)

FeNO is a simple breath test that measures a marker of T2 airway inflammation. A higher level suggests inflammation that may respond well to inhaled steroids and to certain biologic therapies.

Blood tests

Blood tests typically include a full blood count to measure eosinophils, total IgE (an antibody linked to allergy), and sometimes specific IgE to common allergens. These numbers help classify the phenotype and guide biologic choice.

Allergy testing

Skin-prick testing or specific blood allergy tests identify environmental triggers. This is particularly important in severe allergic asthma.

Imaging

A chest X-ray or, in selected cases, a CT scan of the chest and sinuses may be done to rule out other conditions such as bronchiectasis, fungal lung disease (allergic bronchopulmonary aspergillosis), or chronic sinusitis with polyps.

Assessment for related conditions

The specialist will look for and treat conditions that commonly worsen asthma, including nasal disease, reflux, obesity, sleep apnoea, anxiety, and dysfunctional breathing patterns. Addressing these often improves asthma control significantly.

Treatment and Management

Severe asthma management is built in layers. The aim is to use the lowest level of treatment that keeps your asthma well controlled, and to avoid long-term oral steroids wherever possible because of their side effects.

Optimising inhaler therapy

The foundation of treatment is still inhaled medicine. Current GINA guidance recommends a combination of an inhaled corticosteroid (ICS) with a long-acting beta-agonist (LABA) as the preferred preventer and, in many regimens, also as the reliever. This is called MART or single-inhaler therapy.

For severe asthma, additional inhaled medicines may be added:

  • Inhaled corticosteroids (ICS) at higher doses reduce airway inflammation.
  • Long-acting beta-agonists (LABA) relax the airway muscle.
  • Long-acting muscarinic antagonists (LAMA) such as tiotropium can be added as a third controller.
  • Short-acting bronchodilators are still used as rescue medicines in some regimens, but modern guidance has moved away from using them alone, because over-reliance on rescue inhalers is linked to worse outcomes.
Step-by-step illustration of correct metered-dose inhaler use with spacer device showing five sequential technique steps.
Correct metered-dose inhaler technique with spacer: ① shake and attach inhaler to spacer, ② exhale fully before placing mouthpiece, ③ actuate inhaler into spacer chamber, ④ inhale slowly and steadily, ⑤ hold breath for ten seconds.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Add-on oral medicines

Leukotriene receptor antagonists (such as montelukast) may be added in selected cases, particularly where allergy or exercise-induced symptoms are prominent. Theophylline is used less now but is still an option in some settings.

Oral corticosteroids

Short courses of oral steroids (commonly prednisolone) are used to treat exacerbations. Some people with very severe asthma end up taking them daily or every other day. Long-term oral steroids carry significant risks — weight gain, diabetes, osteoporosis, cataracts, mood changes, skin thinning, and increased infection risk — so current guidelines emphasise reducing or stopping them whenever a biologic or other strategy makes this possible.

Biologic therapies

Medical diagram of airway immune cell signalling pathway showing IgE, IL-5, IL-4 IL-13, and TSLP molecular targets for biologic therapies in severe asthma.
T2 inflammatory pathway in severe asthma showing biologic targets: ① IgE blocked by anti-IgE therapy, ② IL-5 signalling blocked by anti-IL-5 therapies, ③ IL-4/IL-13 receptor blocked by anti-IL-4/IL-13 therapy, ④ TSLP at the epithelial surface blocked by anti-TSLP therapy.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Biologics are injectable medicines that target specific pathways in the immune system. They are one of the major changes in severe asthma care over the past decade. They are not for everyone — they are most effective in people whose asthma is driven by T2 inflammation, identified through eosinophil counts, FeNO, and allergy testing.

The main biologic classes currently used in severe asthma include:

  • Anti-IgE therapy (omalizumab) for severe allergic asthma with raised IgE.
  • Anti-IL-5 and anti-IL-5 receptor therapies (mepolizumab, reslizumab, benralizumab) for severe eosinophilic asthma.
  • Anti-IL-4/IL-13 therapy (dupilumab) for severe T2 asthma, especially where there is also nasal polyposis or atopic dermatitis.
  • Anti-TSLP therapy (tezepelumab) for severe asthma across a broader range of phenotypes, including some non-T2 patients.

Biologics are usually given by injection every two to eight weeks depending on the medicine. They are not cures — they reduce exacerbations, improve control, and often allow oral steroid doses to be reduced or stopped. The choice between biologics depends on your phenotype, blood test results, age, related conditions, and how you respond. The decision is made by a specialist team after a structured assessment.

Bronchial thermoplasty

Bronchial thermoplasty is a bronchoscopic procedure that uses controlled heat to reduce the smooth muscle in the airway walls. It is offered only in highly selected adults with severe asthma at specialist centres, usually after biologic options have been considered. It is not a first-line treatment.

Allergen avoidance and immunotherapy

Where a specific allergen is a major driver, focused avoidance strategies and, in selected cases, allergen immunotherapy may be considered as part of the overall plan.

Lifestyle and Self-Management

Medicine alone is rarely enough in severe asthma. Day-to-day self-management is a major part of staying well.

Written asthma action plan

A written action plan tells you what to do when your asthma is well controlled, when it starts to slip, and when it becomes severe. It includes which medicine to take, when to start oral steroids, and when to seek urgent care. Major guidelines including GINA strongly recommend that every person with asthma has one. If you do not have a written plan, ask your specialist to prepare one with you.

Three-panel traffic-light zone diagram of a written asthma action plan showing green well-controlled, yellow worsening, and red emergency zones.
Three-zone asthma action plan framework: ① green zone — well controlled, continue preventer as normal, ② yellow zone — symptoms worsening, increase reliever and consider oral steroids, ③ red zone — severe attack, call emergency services immediately.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Inhaler technique and adherence

Even with the best medicine, poor technique means poor control. Ask to be re-checked at every visit and any time your inhaler device changes. Spacer devices significantly improve drug delivery from metered-dose inhalers.

Avoiding triggers

Common triggers worth identifying and managing include:

  • Tobacco smoke — including second-hand smoke — and vaping
  • Indoor allergens such as dust mites, mould, pets, and cockroach
  • Outdoor air pollution and high-pollen days
  • Cold, dry air and sudden weather changes
  • Respiratory infections, especially viral colds
  • Occupational exposures
  • Some medicines, such as non-steroidal anti-inflammatories and beta-blockers in susceptible people

Weight, exercise, and breathing patterns

Obesity worsens asthma control and reduces response to inhalers. Even modest, sustained weight loss can improve symptoms. Regular, well-paced exercise improves lung capacity and overall fitness; people with severe asthma can usually exercise safely with the right plan, including pre-exercise inhaler use where appropriate. Breathing retraining, often guided by a physiotherapist, helps where dysfunctional breathing patterns are contributing.

Vaccinations

Annual influenza vaccination and recommended pneumococcal and COVID-19 vaccinations are part of routine severe asthma care, because respiratory infections are a major cause of exacerbations.

Mental health

Anxiety and depression are more common in severe asthma. They can also make breathlessness feel worse and reduce adherence to treatment. Addressing mental health is part of full management, not an optional add-on.

Monitoring and Targets

Severe asthma is monitored over time so that treatment can be adjusted up or down. Typical monitoring includes:

  • Symptom control scores (such as the Asthma Control Test) at each visit
  • Number of exacerbations and oral steroid courses since the last review
  • Peak flow recordings at home, where helpful
  • Spirometry at intervals
  • Blood eosinophils and FeNO, particularly when considering or continuing biologics
  • Side-effect review, especially for those still on oral steroids
  • Review of inhaler technique and adherence
Side-by-side cross-section anatomy diagram comparing healthy bronchial airway with remodelled severe asthma airway showing thickened walls and narrowed lumen.
Airway remodelling in severe asthma compared with a healthy airway: ① normal open airway lumen, ② thickened subepithelial layer, ③ increased smooth muscle mass, ④ mucus gland enlargement, ⑤ narrowed remodelled lumen.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
  • Life-threatening exacerbations, sometimes requiring intensive care
  • Airway remodelling, where the airway walls become thickened and less responsive over time
  • Reduced lung function that may not fully reverse
  • Side effects of long-term oral steroids, including bone loss, diabetes, weight gain, mood changes, and adrenal suppression
  • Frequent missed work or school and impact on income and education
  • Anxiety, low mood, and reduced quality of life

Modern phenotype-driven treatment, including biologics where appropriate, has changed this picture for many patients by reducing both exacerbations and the need for oral steroids.

Living With Severe Asthma

Severe asthma is a long-term condition. Living well with it usually involves the following elements:

  • A trusted specialist team that knows your history
  • A current written action plan
  • Confident inhaler use, with technique checked regularly
  • Awareness of your personal triggers and early warning signs
  • Regular review, even when you feel well
  • Honest conversations about adherence, side effects, and how you are coping emotionally
  • Family or close contacts who know how to help during a severe attack

Pregnancy, surgery, and travel can all be planned safely with specialist input. Asthma medicines — including most inhalers and many biologics — are generally continued in pregnancy because uncontrolled asthma poses a greater risk to both mother and baby than the medicines do. Decisions are always individualised.

Severe Asthma in Children

Young child using a metered-dose inhaler with a spacer and face mask held by a parent in a calm home setting.
Young child using a metered-dose inhaler with a spacer and face mask, guided by a parent.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Severe asthma in children is uncommon but real. Most children with apparently uncontrolled asthma have one of the reversible factors mentioned earlier — technique, adherence, ongoing exposure, or untreated allergies. A paediatric specialist assessment focuses on confirming the diagnosis and identifying these factors before escalating treatment.

Key points specific to children with severe asthma include:

  • Diagnosis can be more difficult in young children because spirometry is harder to perform reliably under the age of five or six. Diagnosis often relies on symptom pattern, response to treatment, and allergy testing.
  • Inhaler delivery in young children uses a spacer with a face mask or mouthpiece, depending on age. Technique training for both child and parent is essential.
  • Allergy is a particularly common driver in childhood severe asthma. Identifying and reducing key allergens at home can have a big effect.
  • Schools should have a copy of the child’s action plan and access to their reliever inhaler. Asthma should not stop a child taking part in sport or school activities when control is good.
  • Biologic therapies are licensed in older children for specific phenotypes. The available options and age limits vary by medicine, and the choice is made by a paediatric specialist.
  • Long-term oral steroids are avoided in children wherever possible because of effects on growth, bone health, and metabolism.
  • Mental health and family stress matter. Severe asthma affects sleep, school attendance, and family routines, and families benefit from support.

The aim in children, as in adults, is good control with the lowest effective treatment, normal activity, and normal growth.

Preventing Exacerbations

An exacerbation (also called a flare-up or attack) is a worsening of symptoms that needs extra treatment. Reducing exacerbations is one of the main goals of severe asthma management.

Strategies that reduce exacerbations include:

  • Taking the preventer inhaler every day, even when you feel well
  • Following the written action plan, including stepping treatment up early at the first signs of worsening
  • Annual influenza vaccination and other recommended vaccines
  • Avoiding identified triggers where possible
  • Treating related conditions such as nasal polyps, reflux, and sleep apnoea
  • Starting an appropriate biologic where indicated
  • Stopping smoking and reducing exposure to second-hand smoke and indoor pollution

When to Seek Urgent Care

Even with good management, severe asthma can flare. Knowing when an attack is becoming dangerous is an essential safety skill.

Seek urgent medical care — including emergency services — if you or your child experience any of the following:

  • The reliever inhaler is not helping, or its effect wears off within a few hours
  • You are too breathless to speak in full sentences
  • Lips or fingertips look blue or grey
  • The chest is sucking in between the ribs or at the base of the neck with each breath
  • You feel exhausted, drowsy, or confused
  • A child is too breathless to feed, drink, or play
  • Peak flow drops sharply below your personal best, as set out in your action plan

Do not wait to see if it improves. Severe attacks can worsen quickly, and earlier treatment is safer and more effective.

Frequently Asked Questions

Is severe asthma curable?

Severe asthma is not currently curable, but it is highly treatable. The goal of modern management is long-term control with normal activity, few or no exacerbations, and minimal medicine side effects.

Will I always need to be on inhalers?

Most people with severe asthma stay on some form of inhaler therapy long term, because the underlying airway inflammation continues even when symptoms are well controlled. Treatment intensity can often be reduced once asthma is stable, but stopping preventer inhalers entirely is unusual.

How are biologics decided on?

The choice depends on your phenotype, blood test results (eosinophils, IgE), FeNO, allergy testing, related conditions such as nasal polyps, and treatment history. A specialist team reviews all of this together. There is rarely a single “best” biologic — the goal is the best fit for your specific pattern.

Are biologics safe?

Biologics have been used in asthma for over a decade and have a good safety profile in studies and in routine practice. The most common side effects are mild injection-site reactions. Rare side effects include allergic reactions. They are prescribed and monitored by specialists.

Can I exercise with severe asthma?

Yes, with appropriate planning. Regular exercise improves fitness, breathing, and quality of life. Your specialist can advise on warm-up routines, pre-exercise inhaler use, and which symptoms should make you pause.

Is it safe to be pregnant with severe asthma?

Yes, with planning. Most asthma medicines, including inhaled steroids and many biologics, are continued in pregnancy because uncontrolled asthma is more harmful to both mother and baby than the medicines. Pregnancy plans should be discussed with both your obstetrician and your asthma specialist.

Will my child grow out of severe asthma?

Some children’s asthma improves around adolescence. Others continue to have asthma into adult life. Severe childhood asthma, particularly when associated with strong allergy or low lung function, more often persists. Long-term follow-up is important even if symptoms ease.

Why do I need a specialist if my GP has been managing my asthma?

Severe asthma management often needs phenotype testing, biologic decisions, and the unwinding of long-term oral steroids — tasks that sit in specialist care. Your primary care doctor remains an important part of the team for day-to-day care and acute exacerbations.

Conclusion

Severe asthma is one of the most demanding forms of a common condition. It can disrupt sleep, work, school, exercise, and confidence. It is also one of the areas of respiratory medicine where care has changed the most in recent years.

Modern management starts with careful assessment — confirming the diagnosis, checking inhaler technique and adherence, identifying triggers, and treating related conditions. From there, treatment is matched to your phenotype, with biologic therapies available for many people whose asthma is driven by T2 inflammation. The aim is steady control, fewer attacks, less reliance on oral steroids, and a life that is shaped by you rather than by your asthma.

If you are at the point of moving into specialist care, the next steps are usually a detailed assessment, phenotype testing, a written action plan, and a clear treatment pathway built around your specific pattern of disease.

Plan your treatment

Severe Asthma Management in India — save up to 70% vs US/UK

Connect with 91+ specialists across 38 JCI/NABH hospitals. See cost details, compare hospitals, and meet the specialists.

Your Health Deserves the Best — Not the Most Expensive

Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.

🔒 100% Free🏥 JCI Accredited💬 Counsellors Online🤝 No Obligation